(0.23%) 5 534.25 points
(0.23%) 39 561 points
(0.23%) 19 974 points
(0.67%) $82.09
(-1.88%) $2.55
(0.30%) $2 346.70
(0.03%) $29.57
(-0.54%) $996.50
(-0.26%) $0.931
(-0.27%) $10.65
(-0.16%) $0.789
(2.08%) $87.51
@ $79.70
发出时间: 29 Jun 2024 @ 03:48
回报率: 0.74%
上一信号: Jun 28 - 23:02
上一信号:
回报率: -1.93 %
Live Chart Being Loaded With Signals
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide...
Stats | |
---|---|
今日成交量 | 1.02M |
平均成交量 | 821 751 |
市值 | 5.57B |
EPS | $1.910 ( Q1 | 2024-05-02 ) |
下一个收益日期 | ( $1.830 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
12.24 (Sector) 42.63 (Industry) 0 |
ATR14 | $3.41 (4.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-17 | Humphrey Jeffrey | Buy | 16 188 | Stock Option (right to buy) |
2024-06-17 | Humphrey Jeffrey | Buy | 9 076 | Common Stock |
2024-06-13 | Sabens Andrea | Sell | 341 | Common Stock |
2024-05-28 | Humphrey Jeffrey | Sell | 0 | Common Stock |
2024-05-31 | Blanchfield Paul | Sell | 1 179 | Common Stock |
INSIDER POWER |
---|
19.53 |
Last 100 transactions |
Buy: 655 708 | Sell: 450 988 |
音量 相关性
Lantheus Holdings Inc 相关性
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Lantheus Holdings Inc 相关性 - 货币/商品
Lantheus Holdings Inc 财务报表
Annual | 2023 |
营收: | $1.30B |
毛利润: | $709.54M (54.73 %) |
EPS: | $4.79 |
FY | 2023 |
营收: | $1.30B |
毛利润: | $709.54M (54.73 %) |
EPS: | $4.79 |
FY | 2022 |
营收: | $935.06M |
毛利润: | $581.70M (62.21 %) |
EPS: | $0.410 |
FY | 2021 |
营收: | $425.21M |
毛利润: | $187.70M (44.14 %) |
EPS: | $-1.054 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。